CLINICAL_TRIALS
trial_result
· 2015-09-17
Clinical Trial Update: Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer [Phase 2]
Summary
A Phase 2 trial evaluating combined modality therapy for HIV-infected patients with anal cancer has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AIDS Malignancy Consortium | Conditions: Anal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-09-17